Publications by authors named "Anabelle Tardif-Samson"

Claim this Profile
P
Profiles of Medicaid Beneficiaries with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray.
Kristin Clemens, Maryia Zhdanava, Amanda Teeple, Arthur Voegel, Aditi Shah, Anabelle Tardif-Samson

Neurol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USA.
Manish K Jha, Maryia Zhdanava, Aditi Shah, Arthur Voegel, Anabelle Tardif-Samson

Drugs Real World Outcomes· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease.
David Mannino, Stephen Weng, Guillaume Germain, Julien Boudreau, Anabelle Tardif-Samson

Adv Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy.
Scott F Huntington, Dee Lin, Marie-Hélène Lafeuille, Philippe Thompson-Leduc, Aditi Shah, Anabelle Tardif-Samson

Pharmacol Res Perspect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall burden and impact on health-related quality of life associated with intravesical treatment of patients with non-muscle invasive bladder cancer in the United States.
Todor I Totev, Andrea Ireland, Aditi Shah, Anabelle Tardif-Samson, Patrick Lefebvre

Curr Med Res Opin· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Time to Next Treatment or Death Between Front-Line Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) Among Transplant-Ineligible Patients With Multiple Myeloma.
Doris K Hansen, Santosh Gautam, Marie-Hélène Lafeuille, Carmine Rossi, Bronwyn Moore, Anabelle Tardif-Samson

Cancer Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer.
Franklin D Gaylis, Bruno Emond, Ameur M Manceur, Anabelle Tardif-Samson, Laura Morrison

J Health Econ Outcomes Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding profiles of patients with treatment-resistant depression by stringency of health plan prior authorization criteria for approval of esketamine nasal spray.
Lisa Harding, Maryia Zhdanava, Aditi Shah, Jacqueline Pesa, Todor I Totev, Anabelle Tardif-Samson

Curr Med Res Opin· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based Analysis.
Michael Ingham, Hela Romdhani, Aarti Patel, Veronica Ashton, Gabrielle Caron-Lapointe, Anabelle Tardif-Samson

J Mark Access Health Policy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis